Trademark Overview
On Tuesday, September 23, 2025, a trademark application was filed for NEUVASQ with the United States Patent and Trademark Office. The USPTO has given the NEUVASQ trademark a serial number of 79439015. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Wednesday, February 4, 2026. This trademark is owned by Neuvasq Biotechnologies, naamloze vennootschap. The NEUVASQ trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations; pharmaceuticals and medicines for the treatment and prevention of neurological disorders; pharmaceuticals and medicines for the treatment and prevention of neurodegenerative diseases; pharmaceutical preparations and substances for the treatment of eye diseases and conditions; pharmaceuticals and medicines for the treatment and prevention of bone disorders and conditions, therapeutic preparations for the management of retinal disorders; injectable pharmaceuticals for the treatment of ocular diseases and neurological disorders.
Medical and pharmacological research services; pharmaceutical research and development of pharmaceuticals and medicines; pharmaceutical research and development of pharmaceutical products and medicines for the treatment and prevention of neurological disorders, eye diseases and bone disorders.
